You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ruxolitinib

Showing 326 - 345 of 345
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial (Allogenic transplantation transplantation)

Not yet recruiting
  • Myelofibrosis
  • Allogenic transplantation transplantation
  • (no location specified)
Jan 24, 2021

Thalassemia Major Trial in Worldwide (ruxolitinib)

Completed
Has Results
  • Thalassemia Major
  • ruxolitinib
  • Athens, GR, Greece
  • +6 more
Jun 19, 2017

Breast Cancer Trial in Boston (Ruxolitinib)

Terminated
Has Results
  • Breast Cancer
  • Ruxolitinib
  • Boston, Massachusetts
  • +1 more
Jan 3, 2017

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Toronto (ruxolitinib, ibrutinib)

Unknown status
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Toronto, Ontario, Canada
  • +1 more
Mar 8, 2017

MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (Ruxolitinib, Placebo)

Completed
Has Results
  • MPN (Myeloproliferative Neoplasms)
  • Ruxolitinib
  • Placebo
  • Birmingham, Alabama
  • +111 more
Feb 12, 2018

Myeloproliferative Tumor, Primary Myelofibrosis, Essential Thrombocythemia Trial in Switzerland (Mirabegron)

Completed
  • Myeloproliferative Neoplasm
  • +3 more
  • Aarau, Switzerland
  • +10 more
May 13, 2019

Polycythemia Vera, Essential Thrombocythemia Trial in Washington, New York, Winston-Salem (RG7388, Pegasys)

Completed
  • Polycythemia Vera
  • Essential Thrombocythemia
  • Washington, District of Columbia
  • +2 more
Sep 11, 2019

Myelofibrosis Trial in Worldwide (INC424)

Completed
Has Results
  • Myelofibrosis
  • Alger, Algeria
  • +272 more
Apr 25, 2019

Chronic Lymphocytic Leukemia Trial in Toronto (Ruxolitinib)

Completed
  • Chronic Lymphocytic Leukemia
  • Ruxolitinib
  • Toronto, Ontario, Canada
    Sunnybrook Odette Cancer Center
Sep 23, 2016

Myelofibrosis, MF Trial (RUXOLITINIB / INC 424, Filgrastim, Busulfan)

Withdrawn
  • Myelofibrosis
  • MF
  • RUXOLITINIB / INC 424
  • +2 more
  • (no location specified)
Aug 11, 2016

Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis Trial in Worldwide (Pomalidomide, Prednisone, Placebo

Completed
Has Results
  • Myelofibrosis With Myeloid Metaplasia
  • +2 more
  • Los Angeles, California
  • +10 more
Nov 7, 2019

Myelofibrosis Trial in Atlanta, New York (Peginterferon alfa-2a)

Terminated
Has Results
  • Myelofibrosis
  • Peginterferon alfa-2a
  • Atlanta, Georgia
  • +1 more
Jun 28, 2018

Acute Myeloid Leukemia in Remission, Primary Myelofibrosis, Primary Myelofibrosis, Prefibrotic Stage Trial in Duarte (procedure,

Withdrawn
  • Acute Myeloid Leukemia in Remission
  • +4 more
  • Allogeneic Bone Marrow Transplantation
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Sep 12, 2016

Primary Myelofibrosis (MF) Trial in Japan (Ruxolitinib)

Completed
Has Results
  • Primary Myelofibrosis (MF)
  • Ruxolitinib
  • Nagoya-city, Aichi, Japan
  • +28 more
May 26, 2016

Primary Myelofibrosis Trial in Leipzig, Firenze, Madrid (Ruxolitinib)

Terminated
Has Results
  • Primary Myelofibrosis
  • Ruxolitinib
  • Leipzig, Germany
  • +2 more
Feb 24, 2016

Hematopoietic Tumor Trial in Worldwide (SAR302503)

Completed
  • Hematopoietic Neoplasm
  • Phoenix, Arizona
  • +41 more
Feb 17, 2016

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • ruxolitinib phosphate
  • +2 more
  • Birmingham, Alabama
  • +23 more
Oct 22, 2014

Myelofibrosis Trial in Scottsdale, Winter Park, Houston (Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Ruxolitinib
  • Scottsdale, Arizona
  • +2 more
Feb 5, 2014

Primary Myelofibrosis (PMF), Post Polycythaemia Myelofibrosis (PPV MF), Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

Completed
Has Results
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Cardiff, Wales, United Kingdom
  • +9 more
Mar 1, 2015

Hematological Malignancies Trial in Pavia

Unknown status
  • Hematological Malignancies
    • Pavia, Italy
      Department of Hematology Oncology, IRCCS Policlinico San Matteo
    Jun 4, 2015